Guido Gerken

发表

Epithelial cell-derived components induce transforming growth factor-α mRNA expression and epithelial cell proliferation in vitro

G. Holtmann, A. Dignass, P. Hoffmann, 2001, European journal of gastroenterology & hepatology.

Expression of insulin-like growth factor binding proteins and collagen in experimental colitis in rats

G. Gerken, M. Reinshagen, N. Riley, 2001, European journal of gastroenterology & hepatology.

Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis—The 20-Year Experience of a High-Volume Tertiary Center

A. Kahraman, W. Siffert, B. Möhlendick, 2023, Journal of clinical medicine.

Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells.

G. Gerken, A. Lohse, T. Germann, 1999, Gastroenterology.

The Relationship Between Apoptosis and Non-Alcoholic Fatty Liver Disease: An Evolutionary Cornerstone Turned Pathogenic

G. Gores, R. Gieseler, A. Canbay, 2005, Zeitschrift fur Gastroenterologie.

Detection of hepatitis C virus in paraffin‐embedded liver biopsies of patients negative for viral RNA in serum

P. Schirmacher, M. Odenthal, G. Gerken, 1999, Hepatology.

A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti‐hepatitis B virus surface antigen immunoprophylaxis

T. Berg, G. Gerken, W. Bechstein, 1997, Hepatology.

Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.

P. Galle, G. Gerken, A. Lohse, 1999, Journal of hepatology.

Acute Management of Refractory Variceal Bleeding in Liver Cirrhosis by Self-Expanding Metal Stents

G. Gerken, L. Bechmann, A. Dechêne, 2012, Digestion.

Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis.

G. Gerken, H. Dienes, A. Lohse, 1996, Journal of hepatology.

Duration of immunosuppressive therapy in autoimmune hepatitis.

G. Gerken, A. Lohse, K. Meyer zum Büschenfelde, 2001, Journal of hepatology.

HLA-DRB1*1301 and *1302 protect against chronic hepatitis B.

G. Gerken, P. Schneider, U. Protzer, 1997, Journal of hepatology.

Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology.

G. Gerken, H. Dienes, B. Fleischer, 2008, Liver.

Role of sinusoidal endothelial cells of the liver in concanavalin A‐induced hepatic injury in mice

G. Gerken, H. Dienes, A. Lohse, 1996, Hepatology.

Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity

J. Debatin, G. Gerken, S. Ruehm, 2005, Gut.

Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function.

G Gerken, G. Gerken, D. Podolsky, 2007, Gastroenterology.

The safety of pegylated interferon alpha‐2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation

G. Gerken, S. Zeuzem, U. Akarca, 2005, Alimentary pharmacology & therapeutics.

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

P. Andersen, H. Thomas, G. Gerken, 1994, Journal of hepatology.

Analytical Performance Characteristics and Clinical Utility of a Novel Assay for Total Hepatitis C Virus Core Antigen Quantification

G. Gerken, P. Hilgard, R. S. Ross, 2010, Journal of Clinical Microbiology.

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen.

G. Gerken, J. Wands, C. Bréchot, 1990, The New England journal of medicine.

Performance characteristics of the VERSANT hepatitis C virus RNA 1.0 (kPCR) assay.

K. Korn, G. Gerken, R. S. Ross, 2015, International journal of medical microbiology : IJMM.

Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation.

G. Gerken, M. Malago', C. Broelsch, 2000, Journal of hepatology.

Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge.

G. Gerken, P. Knolle, K. Meyer zum Büschenfelde, 1995, Journal of hepatology.

Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation

G. Gerken, V. Cicinnati, S. Beckebaum, 2007, Alimentary pharmacology & therapeutics.

Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients

G. Gerken, V. Cicinnati, S. Beckebaum, 2009, Alimentary pharmacology & therapeutics.

Long‐term stimulation of Toll‐like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I:C treatment

G. Gerken, A. Paul, M. Trippler, 2014, Journal of viral hepatitis.

Impairment of health‐related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety

G. Gerken, N. Talley, G. Holtmann, 2008, Alimentary pharmacology & therapeutics.

Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients – assessment of renal and allograft function, cardiovascular risk factors and immune monitoring

G. Gerken, V. Cicinnati, S. Beckebaum, 2007, Alimentary pharmacology & therapeutics.

Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection.

V. Cicinnati, S. Beckebaum, A. Radtke, 2008, Transplantation proceedings.

Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA.

P. Simmonds, G. Gerken, P. Pontisso, 1996, Journal of hepatology.

HBV viral load within subpopulations of peripheral blood mononuclear cells in HBV infection using limiting dilution PCR.

G. Gerken, K. Meyer zum Büschenfelde, K. Büschenfelde, 1999, Journal of virological methods.